ArticleMagma (New York, N.Y.)2026
MRI-based texture analysis for breast cancer subtype classification in a multi-ethnic population.
Article in Magma (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the recurrence and metastasis of breast invasive ductal carcinoma based on machine learning and survival analysis.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionBreast cancer, the most prevalent cancer among women globally, is classified into molecular subtypes (luminal, HER2-enriched, and triple-negative) to guide treatment and prognosis. Traditional subtyping methods, such as gene profiling and immunohistochemistry, are invasive and limited by intratumoural heterogeneity. MRI radiomics analysis offers a non-invasive alternative by extracting quantitative imaging features, yet its application in diverse, multi-ethnic populations remains underexplored.
objectiveThis study aimed to identify predictive radiomic features from multiple MRI sequences to classify breast cancer subtypes, compare the performance of four MRI sequences, and determine the optimal machine learning (ML) model for this task. A total of 162 retrospective breast cancer MRI cases were semi-automatically segmented, and 256 radiomic features were extracted. A multimodal ML framework integrating random forest and recursive feature elimination was developed to identify the most predictive features based on the area under the receiver operating characteristic curve (AUROC).
resultsKey predictive features included age, tumour size, margin characteristics, and intensity patterns within the tumour. Among MRI sequences, inversion recovery and T1 post-contrast performed best for subtyping. In addition, texture-based ML models effectively emulated visual assessment, demonstrating the potential of radiomics in non-invasive breast cancer subtyping. With the top ten features, the AUROC values are 0.735, 0.630, and 0.747 for luminal, HER2-enriched, and triple-negative, respectively.
conclusionThese findings highlight the role of MRI-based texture features and advanced ML in enhancing breast cancer diagnosis, offering a non-invasive tool for personalised treatment planning while complementing existing clinical workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.